ARDX - Ardelyx Inc logo

ARDX

Ardelyx Inc

Ardelyx, Inc. develops and commercializes biopharmaceutical products for unmet medical needs. Its key offerings include IBSRELA for irritable bowel syndrome with constipation and XPHOZAH, which reduces serum phosphorus in chronic kidney disease patients.

โš•๏ธ Healthcare NASDAQ Listed 2014 $ USD
$1,000 invested 10 years ago โ†’$388today

Score Overview

1 Year
Score
Net Growth5.75%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth5.00%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score7.5
Net Growth63.29%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth42x
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth48.34%
Net Trend60%
Net Income Consistency
Rev Growth17x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth-16x
Net Trend50%
Net Income Consistency
Rev Growth13x
Rev Trend75%
Revenue Consistency

See the full market ranking โ†’

Ardelyx Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 7M to $ 407M and net income went from -$ 94M to -$ 61M. Revenue increased in every one of those 5 years; net income in 4.

Between 2015 and 2025, revenue grew from $ 24M to $ 407M and net income went from -$ 29M to -$ 61M. Revenue increased in 9 of those 10 years; net income in 6.

Ardelyx Inc currently holds a 5-year HDB Score of 7.5 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-13
$ 3.91โ€”
1 Year2025-08-13
$ 5.75-32.00%
5 Years2021-08-13
$ 1.44171.53%
10 Years2016-08-12
$ 10.08-61.21%
All Time2014-06-19
$ 14.11-72.29%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 427M-$ 58M$ 238M
2025$ 407M-$ 61M$ 264M
2024$ 333M-$ 39M$ 250M
2023$ 124M-$ 66M$ 184M
2022$ 52M-$ 67M$ 123M
2021$ 10M-$ 158M$ 116M
2020$ 7M-$ 94M$ 186M
2019$ 5M-$ 94M$ 247M
2018$ 2M-$ 91M$ 168M
2017$ 42M-$ 64M$ 133M
2016$ 24M-$ 112M$ 200M
2015$ 24M-$ 29M$ 107M
IPO2014$ 31M-$ 3M$ 107M

Explore beyond ARDX

You're looking at Ardelyx Inc. Members apply the same fundamental framework across all 3,859 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies